Warby Parker (WRBY) Revenue & Revenue Breakdown
Warby Parker Revenue Highlights
Latest Revenue (Y)
$771.32M
Latest Revenue (Q)
$190.64M
Main Segment (Y)
Eyewear Products
Warby Parker Revenue by Period
Warby Parker Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $771.32M | 15.16% |
| 2023-12-31 | $669.76M | 11.98% |
| 2022-12-31 | $598.11M | 10.60% |
| 2021-12-31 | $540.80M | 37.36% |
| 2020-12-31 | $393.72M | 6.28% |
| 2019-12-31 | $370.46M | - |
Warby Parker generated $771.32M in revenue during NA 2024, up 15.16% compared to the previous quarter, and up 208.20% compared to the same period a year ago.
Warby Parker Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $190.64M | -0.94% |
| 2024-09-30 | $192.45M | 2.24% |
| 2024-06-30 | $188.22M | -5.89% |
| 2024-03-31 | $200.00M | 23.57% |
| 2023-12-31 | $161.85M | -4.71% |
| 2023-09-30 | $169.85M | 2.26% |
| 2023-06-30 | $166.09M | -3.42% |
| 2023-03-31 | $171.97M | 17.39% |
| 2022-12-31 | $146.49M | -1.54% |
| 2022-09-30 | $148.78M | -0.57% |
| 2022-06-30 | $149.62M | -2.35% |
| 2022-03-31 | $153.22M | 15.30% |
| 2021-12-31 | $132.89M | -3.26% |
| 2021-09-30 | $137.37M | 4.42% |
| 2021-06-30 | $131.56M | -5.33% |
| 2021-03-31 | $138.97M | 23.16% |
| 2020-12-31 | $112.84M | 8.40% |
| 2020-09-30 | $104.09M | 17.76% |
| 2020-06-30 | $88.39M | - |
| 2020-03-31 | $88.39M | - |
Warby Parker generated $190.64M in revenue during Q4 2024, up -0.94% compared to the previous quarter, and up 112.24% compared to the same period a year ago.
Warby Parker Revenue Breakdown
Warby Parker Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|
| Eyewear Products | $730.80M | $568.73M | $522.96M |
| Services And Other | $40.51M | $29.38M | $17.84M |
Latest
Warby Parker's latest annual revenue breakdown by segment (product or service), as of Dec 24: Eyewear Products (94.75%), and Services And Other (5.25%).
Quarterly Revenue by Product
| Product/Service | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eyewear Products | $210.84M | $367.57M | $175.62M | $187.62M | $159.80M | $156.68M | $162.35M | $137.61M | $140.82M | $142.99M | $147.32M | $127.63M | $133.04M |
| Services And Other | $12.94M | $11.30M | $16.83M | $12.38M | $10.05M | $9.41M | $9.62M | $8.88M | $7.96M | $6.64M | $5.90M | $5.26M | $4.34M |
Latest
Warby Parker's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Eyewear Products (94.22%), and Services And Other (5.78%).
Warby Parker Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and | $20.18B | $5.27B |
| ALC | Alcon | $10.09B | $2.46B |
| RMD | ResMed | $4.69B | $1.22B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.90B | $964.70M |
| ATR | AptarGroup | $3.58B | $887.30M |
| TFX | Teleflex | $3.05B | $700.67M |
| WST | West Pharmaceutical Services | $2.89B | $698.00M |
| ICUI | ICU Medical | $2.38B | $629.80M |
| HAE | Haemonetics | $1.36B | $348.54M |
| MMSI | Merit Medical Systems | $1.30B | $355.35M |
| WRBY | Warby Parker | $771.32M | $190.64M |
| ANGO | AngioDynamics | $303.91M | $72.00M |
| LMAT | LeMaitre Vascular | $219.86M | $59.87M |
| BLFS | BioLife Solutions | $82.25M | $-3.42M |
| PDEX | Pro-Dex | $53.84M | $17.41M |
| KRMD | KORU Medical Systems | $33.65M | $8.84M |
| NVST | Envista | - | $616.90M |